297 related articles for article (PubMed ID: 37848630)
1. Oxidized phospholipids in cardiovascular disease.
Tsimikas S; Witztum JL
Nat Rev Cardiol; 2024 Mar; 21(3):170-191. PubMed ID: 37848630
[TBL] [Abstract][Full Text] [Related]
2. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein(a), Oxidized Phospholipids, and Coronary Artery Disease Severity and Outcomes.
Gilliland TC; Liu Y; Mohebi R; Miksenas H; Haidermota S; Wong M; Hu X; Cristino JR; Browne A; Plutzky J; Tsimikas S; Januzzi JL; Natarajan P
J Am Coll Cardiol; 2023 May; 81(18):1780-1792. PubMed ID: 37137588
[TBL] [Abstract][Full Text] [Related]
4. Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).
Tsimikas S; Duff GW; Berger PB; Rogus J; Huttner K; Clopton P; Brilakis E; Kornman KS; Witztum JL
J Am Coll Cardiol; 2014 May; 63(17):1724-34. PubMed ID: 24530664
[TBL] [Abstract][Full Text] [Related]
5. Heritability of Biomarkers of Oxidized Lipoproteins: Twin Pair Study.
Rao F; Schork AJ; Maihofer AX; Nievergelt CM; Marcovina SM; Miller ER; Witztum JL; O'Connor DT; Tsimikas S
Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1704-11. PubMed ID: 25953646
[TBL] [Abstract][Full Text] [Related]
6. Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a).
Yeang C; Hung MY; Byun YS; Clopton P; Yang X; Witztum JL; Tsimikas S
J Clin Lipidol; 2016; 10(3):594-603. PubMed ID: 27206947
[TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.
Merki E; Graham MJ; Mullick AE; Miller ER; Crooke RM; Pitas RE; Witztum JL; Tsimikas S
Circulation; 2008 Aug; 118(7):743-53. PubMed ID: 18663084
[TBL] [Abstract][Full Text] [Related]
8. Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study.
Tsimikas S; Clopton P; Brilakis ES; Marcovina SM; Khera A; Miller ER; de Lemos JA; Witztum JL
Circulation; 2009 Apr; 119(13):1711-9. PubMed ID: 19307470
[TBL] [Abstract][Full Text] [Related]
9. Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events.
Taleb A; Witztum JL; Tsimikas S
Biomark Med; 2011 Oct; 5(5):673-94. PubMed ID: 22003918
[TBL] [Abstract][Full Text] [Related]
10. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
Tsimikas S; Witztum JL; Miller ER; Sasiela WJ; Szarek M; Olsson AG; Schwartz GG;
Circulation; 2004 Sep; 110(11):1406-12. PubMed ID: 15353498
[TBL] [Abstract][Full Text] [Related]
11. Acute impact of apheresis on oxidized phospholipids in patients with familial hypercholesterolemia.
Arai K; Orsoni A; Mallat Z; Tedgui A; Witztum JL; Bruckert E; Tselepis AD; Chapman MJ; Tsimikas S
J Lipid Res; 2012 Aug; 53(8):1670-8. PubMed ID: 22628616
[TBL] [Abstract][Full Text] [Related]
12. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
[TBL] [Abstract][Full Text] [Related]
13. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
[TBL] [Abstract][Full Text] [Related]
14. Associations between lipoprotein(a), oxidized phospholipids, and extra-coronary vascular disease.
Bellomo TR; Liu Y; Gilliland TC; Miksenas H; Haidermota S; Wong M; Hu X; Cristino JR; Browne A; Plutzky J; Tsimikas S; Januzzi JL; Natarajan P
J Lipid Res; 2024 Jun; ():100585. PubMed ID: 38942114
[TBL] [Abstract][Full Text] [Related]
15. A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma.
Bergmark C; Dewan A; Orsoni A; Merki E; Miller ER; Shin MJ; Binder CJ; Hörkkö S; Krauss RM; Chapman MJ; Witztum JL; Tsimikas S
J Lipid Res; 2008 Oct; 49(10):2230-9. PubMed ID: 18594118
[TBL] [Abstract][Full Text] [Related]
16. Oxidation-specific biomarkers and risk of peripheral artery disease.
Bertoia ML; Pai JK; Lee JH; Taleb A; Joosten MM; Mittleman MA; Yang X; Witztum JL; Rimm EB; Tsimikas S; Mukamal KJ
J Am Coll Cardiol; 2013 May; 61(21):2169-79. PubMed ID: 23541965
[TBL] [Abstract][Full Text] [Related]
17. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
18. Oxidized phospholipid modification of lipoprotein(a): Epidemiology, biochemistry and pathophysiology.
Koschinsky ML; Boffa MB
Atherosclerosis; 2022 May; 349():92-100. PubMed ID: 35606081
[TBL] [Abstract][Full Text] [Related]
19. Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS study.
Clarke R; Hammami I; Sherliker P; Valdes-Marquez E; Watkins H; Hill M; Yang X; Tsimikas S; Hopewell JC;
Atherosclerosis; 2022 Aug; 354():15-22. PubMed ID: 35803063
[TBL] [Abstract][Full Text] [Related]
20. New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease.
Tsimikas S; Tsironis LD; Tselepis AD
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2094-9. PubMed ID: 17626905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
